MIMEDX GROUP INC - CO

MIMEDX Appoints Matt Notarianni as Head of Investor Relations

04 10月 2022 07:00:01 条件 Nasdaq GlobeNewswire

MIMEDX Announces Launch of AXIOFILL™

20 9月 2022 07:00:02 条件 Nasdaq GlobeNewswire

MIMEDX Announces Launch of AMNIOEFFECT™

19 9月 2022 06:00:00 条件 Nasdaq GlobeNewswire

MIMEDX EPIFIX® Receives Reimbursement Approval in Japan

12 9月 2022 15:30:00 条件 Nasdaq GlobeNewswire

MIMEDX Announces Leadership Transition

06 9月 2022 06:00:00 条件 Nasdaq GlobeNewswire

Regenerative Engineering Society Establishes Award in Honor of MIMEDX Board Member, Dr. Cato T. Laurencin

26 8月 2022 08:00:00 条件 Nasdaq GlobeNewswire

MIMEDX to Present at the Canaccord Genuity 42nd Annual Growth Conference

04 8月 2022 15:08:43 条件 Nasdaq GlobeNewswire

MIMEDX Announces Second Quarter 2022 Operating and Financial Results

02 8月 2022 15:07:16 条件 Nasdaq GlobeNewswire

MIMEDX Announces Formation of Regenerative Medicine Scientific Advisory Board Comprised of Renowned Industry and Academic Experts

27 7月 2022 07:00:01 条件 Nasdaq GlobeNewswire

MIMEDX to Host Second Quarter 2022 Operating and Financial Results Conference Call on August 3

20 7月 2022 07:00:01 条件 Nasdaq GlobeNewswire

MIMEDX Welcomes Kate Surdez as Chief Human Resources Officer

18 7月 2022 08:35:23 条件 Nasdaq GlobeNewswire

MIMEDX Engages Nordic Bioscience Clinical Development A/S to Propel Registrational Trials of Placental Biologic Injectable for Knee Osteoarthritis

15 6月 2022 07:30:00 条件 Nasdaq GlobeNewswire

MIMEDX Shareholders Vote to Approve All Proposals at the 2022 Annual Meeting

07 6月 2022 15:05:29 条件 Nasdaq GlobeNewswire

MIMEDX Reminds Shareholders to Pre-Register for the Upcoming Virtual 2022 Annual Meeting of Shareholders

03 6月 2022 07:00:00 条件 Nasdaq GlobeNewswire

MIMEDX Addresses Presentation by Prescience Point

02 6月 2022 07:03:35 条件 Nasdaq GlobeNewswire

MIMEDX Board Chair Dr. M. Kathleen Behrens Writes Letter to Fellow Shareholders

31 5月 2022 15:05:00 条件 Nasdaq GlobeNewswire

MIMEDX Receives $4.6 Million Award from the Department of Defense to Advance the Treatment of Combat Casualty Wounds and Burns

31 5月 2022 07:00:01 条件 Nasdaq GlobeNewswire

Leading Independent Proxy Advisory Firm ISS Recommends that MIMEDX Shareholders Vote “FOR ALL” of the Company’s Proposals

25 5月 2022 16:26:30 条件 Nasdaq GlobeNewswire

Leading Independent Proxy Advisory Firm Glass Lewis Recommends that MIMEDX Shareholders Vote “FOR ALL” of the Company’s Proposals

20 5月 2022 08:00:00 条件 Nasdaq GlobeNewswire

MIMEDX Investor Presentation Highlights Clear Strategy for Value Creation

18 5月 2022 15:18:33 条件 Nasdaq GlobeNewswire